Dieses Ergebnis aus Springer Nature Journals kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

Efficacy and safety of dapagliflozin in patients hospitalized with COVID-19 with and without type 2 diabetes: a prespecified analysis of the DARE-19 randomized trial

Title:	Efficacy and safety of dapagliflozin in patients hospitalized with COVID-19 with and without type 2 diabetes: a prespecified analysis of the DARE-19 randomized trial
Authors:	Abdel Jawad, Mohammad^{Aff1, Aff2}; Furtado, Remo H. M.^Aff3; Esterline, Russell^Aff4; Oscarsson, Jan^Aff5; Gasparyan, Samvel B.^Aff6; Koch, Gary G.^Aff7; Martinez, Felipe^Aff8; Mukhtar, Omar^Aff9; Verma, Subodh^{Aff10, Aff11, Aff12}; Langkilde, Anna Maria^Aff5; Ambery, Philip^Aff5; Patel, Shachi^{Aff1, Aff2}; Gosch, Kensey^{Aff1, Aff2}; Windsor, Sheryl L.^Aff1; Soares, Ronaldo V. P.^Aff13; Moia, Diogo D. F.^Aff13; Aboudara, Matthew^Aff14; Javaheri, Ali^Aff15; Saraiva, J. F. Kerr^Aff16; Maia, Lilia Nigro^Aff17; Berwanger, Otavio^{Aff18, Aff19}; Sauer, Andrew J.^{Aff1, Aff2, IDs12933025028756_cor1}; Kosiborod, Mikhail N.^{Aff1, Aff2, Aff6}
Source:	Cardiovascular Diabetology. 24(1)
Database:	Springer Nature Journals